1 – 36 of 36
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Chronotropic Incompetence in Parkinson's Disease : A Possible Marker of Severe Disease Phenotype?
2024) In Journal of Parkinson's Disease(
- Contribution to journal › Article
-
Mark
Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion
2024) In Movement Disorders Clinical Practice(
- Contribution to journal › Article
-
Mark
Putaminal T1/T2-weighted ratio is increased in PSP compared to PD and healthy controls, a multi-cohort study
(
- Contribution to journal › Article
-
Mark
PARKIN is not required to sustain OXPHOS function in adult mammalian tissues
(
- Contribution to journal › Article
- 2023
-
Mark
Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington’s disease : a study of linked Swedish National Registries (2002–2019)
(
- Contribution to journal › Article
-
Mark
The Impact of COVID-19 on Parkinson's Disease : A Case-Controlled Registry and Questionnaire Study on Clinical Markers and Patients' Perceptions
(
- Contribution to journal › Article
-
Mark
Age-related differences in the functional topography of the locus coeruleus and their implications for cognitive and affective functions
(
- Contribution to journal › Article
-
Mark
The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases
(
- Contribution to journal › Article
- 2022
-
Mark
Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson’s disease and Lewy body dementia
(
- Contribution to journal › Article
-
Mark
Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
(
- Contribution to journal › Article
-
Mark
PRC2-mediated repression is essential to maintain identity and function of differentiated dopaminergic and serotonergic neurons
(
- Contribution to journal › Article
- 2021
-
Mark
Genetically targeted clinical trials in parkinson’s disease : Learning from the successes made in oncology
(
- Contribution to journal › Scientific review
-
Mark
A multicentre validation study of the diagnostic value of plasma neurofilament light
(
- Contribution to journal › Article
- 2020
-
Mark
Huntingtons sjukdom – kliniska prövningar inger nu optimism - Vanligaste formen av ärftlig neurodegenerativ sjukdom i västvärlden ger svåra symtom och förtidig död
(
- Contribution to journal › Article
-
Mark
Parkinsons sjukdom – heterogen och komplex i sitt kliniska uttryck - Individuella kombinationer av symtom som ändrar sig över tid kräver behandlingsjusteringar och anpassningar
(
- Contribution to journal › Article
-
Mark
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia
(
- Contribution to journal › Article
-
Mark
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
(
- Contribution to journal › Scientific review
- 2019
-
Mark
Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism
(
- Contribution to journal › Article
-
Mark
α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson’s disease patients
2019) In Proceedings of the National Academy of Sciences of the United States of America 116(30). p.15226-15235(
- Contribution to journal › Article
-
Mark
SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation
(
- Contribution to journal › Article
-
Mark
Low prevalence of known pathogenic mutations in dominant PD genes : A Swedish multicenter study
(
- Contribution to journal › Article
- 2018
-
Mark
Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition
2018) In Proceedings of the National Academy of Sciences of the United States of America 115(37). p.8765-8774(
- Contribution to journal › Article
- 2017
-
Mark
In vivo retention of (18)F-AV-1451 in corticobasal syndrome
(
- Contribution to journal › Article
- 2016
-
Mark
α-Synuclein induced toxicity in brain stem serotonin neurons mediated by an AAV vector driven by the tryptophan hydroxylase promoter
(
- Contribution to journal › Article
-
Mark
Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice.
(
- Contribution to journal › Article
-
Mark
Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden
(
- Contribution to journal › Article
- 2015
-
Mark
Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.
(
- Contribution to journal › Article
-
Mark
Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients
(
- Contribution to journal › Article
-
Mark
EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
(
- Contribution to journal › Article
- 2013
-
Mark
Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons
(
- Contribution to journal › Article
- 2012
-
Mark
Controlled-pH Tissue Cleanup Protocol for Signal Enhancement of Small Molecule Drugs Analyzed by MALDI-MS Imaging
(
- Contribution to journal › Article
- 2004
-
Mark
Bioenergy policy and market development in Finland and Sweden
(
- Contribution to journal › Article
-
Mark
Seeing the wood for the trees: 25 years of renewable energy policy in Sweden
(
- Contribution to journal › Article
- 2002
-
Mark
The use of biomass for energy in Sweden - Critical factors and lessons learned
2002) In Report no. 35(
- Book/Report › Report
- 1995
-
Mark
Reducing CO2 Emissions by Substituting Biomass for Fossil Fuel
(
- Contribution to journal › Article
- 1994
-
Mark
Användning av biobränslen för att minska utsläppen av koldioxid i Sverige
1994) In SOU (Bilaga nr 4 i Rapport från Klimatdelegationen)(
- Book/Report › Report